Bone marrow transplantation for Fanconi anemia.

Abstract:

:Fanconi anemia is a genetic disorder associated with diverse congenital abnormalities, progressive bone marrow failure, and increased risk of leukemia and other cancers. Affected persons often die before 30 years of age. Bone marrow transplantation is an effective treatment, but there are few data regarding factors associated with transplant outcome. We analyzed outcomes of HLA-identical sibling (N = 151) or alternative related or unrelated donor (N = 48) bone marrow transplants for Fanconi anemia performed between 1978 and 1994 and reported to the International Bone Marrow Transplant Registry. Fanconi anemia was documented by cytogenetic studies in all cases. Patient, disease, and treatment factors associated with survival were determined using Cox proportional hazards regression. Two-year probabilities (95% confidence interval) of survival were 66% (58% to 73%) after HLA-identical siblings transplants and 29% (18% to 43%) after alternative donor transplants. Younger patient age (P .0001), higher pretransplant platelet counts (P = .04), use of antithymocyte globulin (P = .005), and use of low-dose (15 to 25 mg/kg) cyclophosphamide plus limited field irradiation (P = .009) for pretransplant conditioning and cyclosporine for graft-versus-host disease prophylaxis (P = .002) were associated with increased survival. Bone marrow transplants are effective therapy for Fanconi anemia. The adverse impact of increasing age and lower pretransplant platelet count on transplant outcome favors earlier intervention, especially when there is an HLA-identical sibling donor.

journal_name

Blood

journal_title

Blood

authors

Gluckman E,Auerbach AD,Horowitz MM,Sobocinski KA,Ash RC,Bortin MM,Butturini A,Camitta BM,Champlin RE,Friedrich W,Good RA,Gordon-Smith EC,Harris RE,Klein JP,Ortega JJ,Pasquini R,Ramsay NK,Speck B,Vowels MR,Zhang MJ,

subject

Has Abstract

pub_date

1995-10-01 00:00:00

pages

2856-62

issue

7

eissn

0006-4971

issn

1528-0020

journal_volume

86

pub_type

临床试验,杂志文章

相关文献

BLOOD文献大全
  • Regulation of myelopoiesis through syntenin-mediated modulation of IL-5 receptor output.

    abstract::The granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin (IL)-3/IL-5 receptor family regulates the production and function of myeloid cells. These cytokines signal through receptor complexes that consist of unique ligand-binding alpha-chains and common signaling beta-chains. IL-5 is distinct from IL-3...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208850

    authors: Beekman JM,Verhagen LP,Geijsen N,Coffer PJ

    更新日期:2009-10-29 00:00:00

  • TLR4- and TRIF-dependent stimulation of B lymphocytes by peptide liposomes enables T cell-independent isotype switch in mice.

    abstract::Immunoglobulin class switching from IgM to IgG in response to peptides is generally T cell-dependent and vaccination in T cell-deficient individuals is inefficient. We show that a vaccine consisting of a dense array of peptides on liposomes induced peptide-specific IgG responses totally independent of T-cell help. Ind...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-02-413831

    authors: Pihlgren M,Silva AB,Madani R,Giriens V,Waeckerle-Men Y,Fettelschoss A,Hickman DT,López-Deber MP,Ndao DM,Vukicevic M,Buccarello AL,Gafner V,Chuard N,Reis P,Piorkowska K,Pfeifer A,Kündig TM,Muhs A,Johansen P

    更新日期:2013-01-03 00:00:00

  • cAMP-induced secretion of endothelial von Willebrand factor is regulated by a phosphorylation/dephosphorylation switch in annexin A2.

    abstract::The large multimeric glyocoprotein von Willebrand factor (VWF) is a crucial component of both primary and secondary hemostasis. It is stored in secretory granules of vascular endothelial cells, the Weibel-Palade bodies (WPBs), and is released following stimulation by agonists that raise intracellular Ca(2+) or cyclic ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-12-475251

    authors: Brandherm I,Disse J,Zeuschner D,Gerke V

    更新日期:2013-08-08 00:00:00

  • GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

    abstract::Children with constitutional trisomy 21 (Down syndrome) have an approximately 500-fold increased risk of developing acute megakaryoblastic leukemia (AMKL), a form of acute myeloid leukemia. Unique to newborn infants with Down syndrome is a transient leukemia (TL), also referred to as transient myeloproliferative syndr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-01-0013

    authors: Hitzler JK,Cheung J,Li Y,Scherer SW,Zipursky A

    更新日期:2003-06-01 00:00:00

  • Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).

    abstract::In this cooperative study, we explored the role of the carbohydrate moiety (CHO) of von Willebrand factor (vWF) in supporting platelet adhesion. Because of previous discrepant results, all purification steps and CHO modifications by various enzymes were critically evaluated. Under our conditions, CHO-modified vWF prep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Federici AB,De Romeuf C,De Groot PG,Samor B,Lombardi R,D'Alessio P,Mazurier C,Mannucci PM,Sixma JJ

    更新日期:1988-04-01 00:00:00

  • The ontogeny of a 57-Kd cationic antimicrobial protein of human polymorphonuclear leukocytes: localization to a novel granule population.

    abstract::The ontogeny of a 57-Kd cationic antimicrobial protein (CAP57) that has substantial similarities to bactericidal permeability increasing protein (BPI) has been determined immunocytochemically. CAP57 was detected in the granules of mature peripheral blood neutrophils. However, it was absent from other cells of the peri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pereira HA,Spitznagel JK,Winton EF,Shafer WM,Martin LE,Guzman GS,Pohl J,Scott RW,Marra MN,Kinkade JM Jr

    更新日期:1990-08-15 00:00:00

  • In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation.

    abstract::To investigate whether the migratory ability of peripheral blood-derived CD34+ cells of patients undergoing autologous peripheral blood stem cell transplantation is related to the homing efficiency of these cells, the migration in vitro of these cells was determined and correlated with in vivo hematopoietic recovery. ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.3.799

    authors: Voermans C,Kooi ML,Rodenhuis S,van der Lelie H,van der Schoot CE,Gerritsen WR

    更新日期:2001-02-01 00:00:00

  • Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

    abstract::The present study in patients with aplastic anemia was undertaken to determine whether exposure of recipients to donor blood products 24 hr before preparation with cyclophosphamide (1) enhanced the rate of sustained engraftment of marrow from HLA-identical siblings as suggested by animal experiments, (2) increased the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Storb R,Prentice RL,Banaji M,Witherspoon RP,Sullivan KM,Stewart P,Sanders JE,Mason M,Doney K,Deeg J,Clift RA,Buckner CD,Appelbaum FR,Thomas ED

    更新日期:1983-04-01 00:00:00

  • Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia.

    abstract::Although imatinib, a BCR-ABL tyrosine kinase inhibitor, is used to treat acute Philadelphia chromosome-positive (Ph(+)) leukemia, it does not prevent central nervous system (CNS) relapses resulting from poor drug penetration through the blood-brain barrier. Imatinib and dasa-tinib (a dual-specific SRC/BCR-ABL kinase i...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2008-02-140665

    authors: Porkka K,Koskenvesa P,Lundán T,Rimpiläinen J,Mustjoki S,Smykla R,Wild R,Luo R,Arnan M,Brethon B,Eccersley L,Hjorth-Hansen H,Höglund M,Klamova H,Knutsen H,Parikh S,Raffoux E,Gruber F,Brito-Babapulle F,Dombret H,Dua

    更新日期:2008-08-15 00:00:00

  • Dismal prognostic value of monosomal karyotype in elderly patients with acute myeloid leukemia: a GOELAMS study of 186 patients with unfavorable cytogenetic abnormalities.

    abstract::The prognosis of acute myeloid leukemia (AML) is very poor in elderly patients, especially in those classically defined as having unfavorable cytogenetics. The recent monosomal karyotype (MK) entity, defined as 2 or more autosomal monosomies or combination of 1 monosomy with structural abnormalities, has been reported...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-09-307264

    authors: Perrot A,Luquet I,Pigneux A,Mugneret F,Delaunay J,Harousseau JL,Barin C,Cahn JY,Guardiola P,Himberlin C,Recher C,Vey N,Lioure B,Ojeda-Uribe M,Fegueux N,Berthou C,Randriamalala E,Béné MC,Ifrah N,Witz F,Groupe Ouest

    更新日期:2011-07-21 00:00:00

  • Production of colony-stimulating activity by human natural killer cells: analysis of the conditions that influence the release and detection of colony-stimulating activity.

    abstract::Highly purified natural killer (NK) cell suspensions were tested for their capacity to release colony-stimulating activity (CSA) in vitro. NK cell suspensions comprised primarily CD16+ cells and were devoid of CD3+ T cells, CD15+ monocytes, and of B cells. CSA was detected in the NK cell supernatants and sustained the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pistoia V,Zupo S,Corcione A,Roncella S,Matera L,Ghio R,Ferrarini M

    更新日期:1989-07-01 00:00:00

  • Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols.

    abstract::In France, more than 80% of children with Burkitt's lymphoma or Burkitt's leukemia (ALL3) are now cured with the LMB (B-cell non-Hodgkin's lymphoma and B-ALL) protocols of the Société Française d'Oncologie Pédiatrique, but so far, poor results have been obtained in the few adult studies available. We have analyzed the...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Soussain C,Patte C,Ostronoff M,Delmer A,Rigal-Huguet F,Cambier N,Leprisé PY,François S,Cony-Makhoul P,Harousseau JL

    更新日期:1995-02-01 00:00:00

  • Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.

    abstract::The complex of the serine protease factor IX (FIX) and its cofactor, factor VIII (FVIII), is crucial for propagation of the intrinsic coagulation cascade. Absence of either factor leads to hemophilia, a disabling disorder marked by excessive hemorrhage after minor trauma. FVIII is the more commonly affected protein, e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-353672

    authors: Milanov P,Ivanciu L,Abriss D,Quade-Lyssy P,Miesbach W,Alesci S,Tonn T,Grez M,Seifried E,Schüttrumpf J

    更新日期:2012-01-12 00:00:00

  • Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis.

    abstract::Lactoferrin is a major constituent of polymorphonuclear leukocyte granules and is present in mature neutrophils but not in blasts or promyelocytes. We have isolated a cDNA probe for lactoferrin and used it to study the synthesis of lactoferrin mRNA by normal and leukemic granulocyte precursors. The probe pHL-41 has be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rado TA,Wei XP,Benz EJ Jr

    更新日期:1987-10-01 00:00:00

  • Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease.

    abstract::Allogeneic hematopoietic stem cell transplantation (HSCT) is widely used to treat hematopoietic cell disorders but is often complicated by graft-versus-host disease (GVHD), which causes severe epithelial damage. Here we have investigated longitudinally the effects of induction chemotherapy, conditioning radiochemother...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2013-11-536888

    authors: Munneke JM,Björklund AT,Mjösberg JM,Garming-Legert K,Bernink JH,Blom B,Huisman C,van Oers MH,Spits H,Malmberg KJ,Hazenberg MD

    更新日期:2014-07-31 00:00:00

  • Functional involvement of Akt signaling downstream of Jak1 in v-Abl-induced activation of hematopoietic cells.

    abstract::Activation of intracellular signaling pathways is important for cellular transformation and tumorigenesis. The nonreceptor tyrosine kinases Jak1 and Jak3, which bind to the v-Abl oncoprotein, are constitutively activated in cells transformed with the Abelson murine leukemia virus. A mutant of p160 v-Abl lacking the Ja...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v100.3.966

    authors: Oki S,Limnander A,Danial NN,Rothman PB

    更新日期:2002-08-01 00:00:00

  • Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor.

    abstract::Recent studies performed in mice knocked out for the tumor necrosis factor (TNF ), the lymphotoxin-alpha, or the type I TNF receptor (R), genes have shown that these animals display gross defects in germinal center (GC) formation, suggesting that members of the TNF and TNFR superfamilies are involved in the control of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Corcione A,Ottonello L,Tortolina G,Tasso P,Ghiotto F,Airoldi I,Taborelli G,Malavasi F,Dallegri F,Pistoia V

    更新日期:1997-12-01 00:00:00

  • Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.

    abstract::Signaling through the receptor tyrosine kinase kit controls proliferation and differentiation of hematopoietic precursor cells and mast cells. Somatic point mutations of the receptor that constitutively activate kit signaling are associated with mastocytosis and various hematopoietic malignancies. We generated a Cre/l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-11-189605

    authors: Gerbaulet A,Wickenhauser C,Scholten J,Peschke K,Drube S,Horny HP,Kamradt T,Naumann R,Müller W,Krieg T,Waskow C,Hartmann K,Roers A

    更新日期:2011-02-10 00:00:00

  • Clearance of circulating activated platelets in polycythemia vera and essential thrombocythemia.

    abstract::Essential thrombocythemia (ET) and polycythemia vera (PV) are characterized by persistent platelet activation. The mechanisms involved in their clearance are poorly characterized. In the present study, we report that leukocytes were actively involved in platelet disposal in 51 patients with ET and 30 with PV, but not ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-02-337337

    authors: Maugeri N,Malato S,Femia EA,Pugliano M,Campana L,Lunghi F,Rovere-Querini P,Lussana F,Podda G,Cattaneo M,Ciceri F,Manfredi AA

    更新日期:2011-09-22 00:00:00

  • An evolutionarily ancient mechanism for regulation of hemoglobin expression in vertebrate red cells.

    abstract::The oxygen transport function of hemoglobin (HB) is thought to have arisen ∼500 million years ago, roughly coinciding with the divergence between jawless (Agnatha) and jawed (Gnathostomata) vertebrates. Intriguingly, extant HBs of jawless and jawed vertebrates were shown to have evolved twice, and independently, from ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020004826

    authors: Miyata M,Gillemans N,Hockman D,Demmers JAA,Cheng JF,Hou J,Salminen M,Fisher CA,Taylor S,Gibbons RJ,Ganis JJ,Zon LI,Grosveld F,Mulugeta E,Sauka-Spengler T,Higgs DR,Philipsen S

    更新日期:2020-07-16 00:00:00

  • Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia.

    abstract::To characterize genetic contributions toward aberrant splicing of the hyaluronan synthase 1 (HAS1) gene in multiple myeloma (MM) and Waldenstrom macroglobulinemia (WM), we sequenced 3616 bp in HAS1 exons and introns involved in aberrant splicing, from 17 patients. We identified a total of 197 HAS1 genetic variations (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-141770

    authors: Adamia S,Reichert AA,Kuppusamy H,Kriangkum J,Ghosh A,Hodges JJ,Pilarski PM,Treon SP,Mant MJ,Reiman T,Belch AR,Pilarski LM

    更新日期:2008-12-15 00:00:00

  • How I treat MDS and AML in Fanconi anemia.

    abstract::Fanconi anemia (FA) is the most frequent inherited cause of bone marrow failure (BMF). Most FA patients experience hematopoietic stem cell attrition and cytopenia during childhood, which along with intrinsic chromosomal instability, favor clonal evolution and the frequent emergence in their teens or young adulthood of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-01-583625

    authors: Peffault de Latour R,Soulier J

    更新日期:2016-06-16 00:00:00

  • Donor versus no-donor comparison of newly diagnosed myeloma patients included in the HOVON-50 multiple myeloma study.

    abstract::To prospectively evaluate allogeneic stem cell transplantation (allo-SCT) for myeloma as part of first-line therapy, a donor versus no-donor analysis was performed of patients treated in the HOVON-50 study, a study that was originally designed to examine thalidomide combined with intensive therapy. Two hundred sixty p...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2011-11-393801

    authors: Lokhorst HM,van der Holt B,Cornelissen JJ,Kersten MJ,van Oers M,Raymakers R,Minnema MC,Zweegman S,Janssen JJ,Zijlmans M,Bos G,Schaap N,Wittebol S,de Weerdt O,Ammerlaan R,Sonneveld P

    更新日期:2012-06-28 00:00:00

  • Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.

    abstract::Erythropoietin (EPO) is the hormone necessary for development of erythrocytes from immature erythroid cells. EPO activates Jun N-terminal kinase (JNK), a member of the mitogen-activated protein kinase (MAPK) family in the EPO-dependent murine erythroid HCD57 cells. Therefore, we tested if JNK activity supported prolif...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1754

    authors: Jacobs-Helber SM,Sawyer ST

    更新日期:2004-08-01 00:00:00

  • Dexamethasone augments CXCR4-mediated signaling in resting human T cells via the activation of the Src kinase Lck.

    abstract::Dexamethasone (DM) is a synthetic member of the glucocorticoid (GC) class of hormones that possesses anti-inflammatory and immunosuppressant activity and is commonly used to treat chronic inflammatory disorders, severe allergies, and other disease states. Although GCs are known to mediate well-defined transcriptional ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151803

    authors: Ghosh MC,Baatar D,Collins G,Carter A,Indig F,Biragyn A,Taub DD

    更新日期:2009-01-15 00:00:00

  • Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

    abstract::Globally suppressed T-cell function has been described in many patients with cancer to be a major hurdle for the development of clinically efficient cancer immunotherapy. Inhibition of antitumor immune responses has been mainly linked to inhibitory factors present in cancer patients. More recently, increased frequenci...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0642

    authors: Beyer M,Kochanek M,Darabi K,Popov A,Jensen M,Endl E,Knolle PA,Thomas RK,von Bergwelt-Baildon M,Debey S,Hallek M,Schultze JL

    更新日期:2005-09-15 00:00:00

  • How I treat essential thrombocythemia.

    abstract::In the past 5 years we have witnessed significant advances in both the diagnostic process and optimal therapy for patients with essential thrombocythemia (ET). Insights into the underlying molecular mechanisms have been accompanied by the development of new diagnostic tests and by an improved understanding of the rela...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-270033

    authors: Beer PA,Erber WN,Campbell PJ,Green AR

    更新日期:2011-02-03 00:00:00

  • Hematopoietic precursors resistant to treatment with 4-hydroperoxycyclophosphamide: requirement for an interaction with marrow stroma in addition to hematopoietic growth factors for maximal generation of colony-forming activity.

    abstract::We tested the ability of CD34+lin- precursor cells isolated from marrow after treatment with 4-hydroperoxycyclophosphamide (4HC) to generate colony-forming cells (CFC). In liquid cultures, recombinant human stem cell factor (SCF), in combination with interleukin-1 (IL-1), IL-3, IL-6, granulocyte-macrophage colony-stim...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rowley SD,Brashem-Stein C,Andrews R,Bernstein ID

    更新日期:1993-07-01 00:00:00

  • Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.

    abstract::Severe congenital neutropenia (CN) is a preleukemic bone marrow failure syndrome with a 20% risk of evolving into leukemia or myelodysplastic syndrome (MDS). Patterns of acquisition of leukemia-associated mutations were investigated using next-generation deep-sequencing in 31 CN patients who developed leukemia or MDS....

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-11-538025

    authors: Skokowa J,Steinemann D,Katsman-Kuipers JE,Zeidler C,Klimenkova O,Klimiankou M,Unalan M,Kandabarau S,Makaryan V,Beekman R,Behrens K,Stocking C,Obenauer J,Schnittger S,Kohlmann A,Valkhof MG,Hoogenboezem R,Göhring G,Rein

    更新日期:2014-04-03 00:00:00

  • The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML.

    abstract::Mutations of the NPM1 gene (NPM1mut) are among the most common genetic alterations in acute myeloid leukemia and are suitable for minimal residual disease detection. We retrospectively investigated the prognostic impact of NPM1mut-based minimal residual disease detection from bone marrow for development of relapse by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-10-461749

    authors: Shayegi N,Kramer M,Bornhäuser M,Schaich M,Schetelig J,Platzbecker U,Röllig C,Heiderich C,Landt O,Ehninger G,Thiede C,Study Alliance Leukemia (SAL).

    更新日期:2013-07-04 00:00:00